UNIVERSAL INSURANCE HOLDINGS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNIVERSAL INSURANCE HOLDINGS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $407.93M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $400.98M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $400.14M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $394.87M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $384.81M | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | $387.55M | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $380.21M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $367.96M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $375.46M | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | $360.05M | Feb 28, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.59M | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | $39.83M | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | $35.09M | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | $41.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $6.02M | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | ($16.16M) | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | $35.42M | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | $33.66M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $20.00M | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | ($5.92M) | Feb 28, 2025 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $342.08M | Feb 28, 2025 |
| FY2024 | Dec 31, 2023 | $304.07M | Feb 28, 2025 |
| FY2024 | Dec 31, 2022 | $304.90M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $313.60M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $289.63M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $272.43M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $256.49M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $231.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $221.18M | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $183.78M | Feb 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $381.49M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $137.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $70.97M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $324.52M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $234.38M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $29.35M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $84.60M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $230.11M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $245.01M | Mar 2, 2020 |
| FY2013 | Dec 31, 2013 | $156.96M | Mar 3, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $7.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $4.02M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.90M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $7.23M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $17.22M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $11.31M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $6.73M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $4.62M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $8.22M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.84B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.84B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.32B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.89B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.06B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.76B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.72B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.86B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.45B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.06B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.29B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.47B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.98B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.60B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.63B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.31B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.23B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.36B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.02B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $688.82M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $551.04M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $373.25M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $341.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $287.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $429.70M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $449.26M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $493.90M | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $501.63M | Feb 28, 2022 |
| FY2020 | Dec 31, 2017 | $439.99M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $371.19M | Mar 2, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $757.45M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $596.85M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $560.69M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $517.46M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $563.71M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $567.51M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $573.62M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $553.22M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $464.75M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $381.86M | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $408.87M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $259.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $397.31M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $388.71M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $250.51M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $167.16M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $182.11M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $166.43M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $213.49M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $105.73M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.48M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $101.24M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $102.01M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $102.77M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $103.68M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.46M | Feb 28, 2022 |
| FY2018 | Dec 31, 2018 | $11.40M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $12.87M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $15.03M | Feb 23, 2018 |
| FY2016 | Dec 31, 2015 | $24.05M | Feb 24, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 28, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 27, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Jun 30, 2024 | 1 | Feb 27, 2026 |
| FY2025 | Mar 31, 2024 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 28, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Feb 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.01M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 28.10M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 28.97M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 30.39M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 31.22M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 31.14M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 32.64M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 34.78M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 34.74M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | 35.05M | Mar 1, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $22.32M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $23.28M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $23.77M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $24.19M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $24.55M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $26.11M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $25.51M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $24.00M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $24.19M | Mar 1, 2019 |